Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Cravedi

Showing results (11-20 of 307) with videos related to

Pageof 31
Sort By:
Kidney360|August 28, 2025
Complement and IgM in FSGS: Minor Characters or Leading Actors?Andrea Angeletti, Paolo Cravedi
Transplantation|July 24, 2024
"LIPSTIC" Traces to Track Immune Cell InteractionNina Goerlich, Paolo Cravedi
The New England Journal of Medicine|May 4, 2018
History of Childhood Kidney Disease and Risk of Adult End-Stage Renal DiseaseGiudeppe Castellano, Paolo Cravedi
Kidney International Reports|January 15, 2025
Roxadustat: More Than an Erythropoietic Agent?Andrea Angeletti, Paolo Cravedi
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 11, 2025
Graft biopsy reimagined: Integrating morphology and molecular mapsUmberto Maggiore, Paolo Cravedi
Kidney International. Supplement|November 27, 2008
Treating the kidney to cure the heartPaolo Cravedi, Giuseppe Remuzzi
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia|May 7, 2014
Role of monoclonal antibodies in the treatment of immune-mediated glomerular diseasesJoaquín Manrique, Paolo Cravedi
Kidney360|June 10, 2025
Neutrophils Expression of Decay Accelerating Factor (DAF), a Key Complement Regulator, Has No Impact on Acute Kidney InjuryBarbara Franchin, Paolo Cravedi
Transplantation|February 9, 2026
Updates on Kidney Transplantation From the World Transplant Congress 2025Johan Noble, Paolo Cravedi
Transplantation|September 24, 2025
The Transplantation Awards: Recognizing Key Advancements and the Path Forward for Our CommunityAmy Cross, Paolo Cravedi
Pageof 31

Showing results (11-20 of 307) with videos related to

Sort By:
Pageof 31
Kidney360|August 28, 2025
Complement and IgM in FSGS: Minor Characters or Leading Actors?Andrea Angeletti, Paolo Cravedi
Transplantation|July 24, 2024
"LIPSTIC" Traces to Track Immune Cell InteractionNina Goerlich, Paolo Cravedi
The New England Journal of Medicine|May 4, 2018
History of Childhood Kidney Disease and Risk of Adult End-Stage Renal DiseaseGiudeppe Castellano, Paolo Cravedi
Kidney International Reports|January 15, 2025
Roxadustat: More Than an Erythropoietic Agent?Andrea Angeletti, Paolo Cravedi
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 11, 2025
Graft biopsy reimagined: Integrating morphology and molecular mapsUmberto Maggiore, Paolo Cravedi
Kidney International. Supplement|November 27, 2008
Treating the kidney to cure the heartPaolo Cravedi, Giuseppe Remuzzi
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia|May 7, 2014
Role of monoclonal antibodies in the treatment of immune-mediated glomerular diseasesJoaquín Manrique, Paolo Cravedi
Kidney360|June 10, 2025
Neutrophils Expression of Decay Accelerating Factor (DAF), a Key Complement Regulator, Has No Impact on Acute Kidney InjuryBarbara Franchin, Paolo Cravedi
Transplantation|February 9, 2026
Updates on Kidney Transplantation From the World Transplant Congress 2025Johan Noble, Paolo Cravedi
Transplantation|September 24, 2025
The Transplantation Awards: Recognizing Key Advancements and the Path Forward for Our CommunityAmy Cross, Paolo Cravedi
Pageof 31